New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024
Shu Wei Wong, Yong‐Yu Yang, Hui Chen, Li Xie, Xizhong Shen, Ning‐Ping Zhang, Jian Wu
Topics & Concepts
SteatohepatitisNonalcoholic steatohepatitisMedicineInternal medicineFatty liverDiseaseNonalcoholic fatty liver diseaseLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseasePancreatic function and diabetes